DW-4301

N/A

Report date: 2023/01/07 18:44:10
NME

Base Information

Drug NameDW-4301
Drug Alias NameDW-4301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid metabolism modulators
TargetsUpdating
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaewon Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHyperlipidemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A